Skip to main content

2 Result(s)

within Joleen M. Hubbard Remove this filter Biomedicine, general Remove this filter

and

  1. Article

    Open Access

    Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

    Borderline resectable pancreatic cancers infiltrate into adjacent vascular structures to an extent that makes an R0 resection unlikely when pancreatectomy is performed de novo. In a pilot study, Alliance for C...

    Matthew H. G. Katz, Fang-Shu Ou, Joseph M. Herman, Syed A. Ahmad… in BMC Cancer (2017)

    Download PDF (542 KB) View Article

  2. No Access

    Article

    Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)

    Angiogenesis has been a major target of novel drug development in hepatocellular carcinoma (HCC). It is hypothesized that the combination of two antiangiogenic agents, sorafenib and bevacizumab, will provide g...

    Joleen M. Hubbard, Michelle R. Mahoney, William S. Loui… in Targeted Oncology (2017)